Life Insurance with Kidney Disease | CKD Life Insurance | High Risk

Chronic kidney disease (CKD) is one of the more directly measurable conditions in life insurance underwriting because kidney function can be quantified precisely through eGFR and creatinine levels. CKD Stage 1–2 with preserved function often qualifies at standard rates; Stage 3 results in table ratings; Stage 4–5 or dialysis dependency results in decline at most fully underwritten carriers. The eGFR (estimated glomerular filtration rate), protein in urine, underlying cause of CKD, and rate of progression are the variables that drive everything.

What Underwriters Evaluate for Kidney Disease

eGFR (Kidney Function Level) — The primary metric. eGFR above 60 (CKD Stage 1–2) is viewed most favorably and often qualifies at standard rates. eGFR 45–59 (Stage 3a) typically results in table ratings. eGFR 30–44 (Stage 3b) results in higher table ratings. Below 30 (Stage 4–5) typically results in decline at standard carriers.

Proteinuria (Protein in Urine) — Even at the same eGFR level, significant proteinuria signals more aggressive kidney damage and worsens the underwriting outcome. Well-controlled or absent proteinuria at any CKD stage is viewed more favorably.

Underlying Cause — The cause of CKD matters. Diabetic nephropathy is viewed as having a less favorable prognosis than CKD from other causes. Hypertensive nephropathy that is well-controlled is viewed more favorably. Polycystic kidney disease (PKD) has its own specific underwriting considerations.

Rate of Progression — Stable kidney function over 12–24 months is viewed much more favorably than declining function. Carriers look at the trend in eGFR values over time. Rapid progression raises significant concern regardless of the current eGFR level.

Dialysis Status — Dialysis dependency (CKD Stage 5D) results in decline at all fully underwritten carriers. Guaranteed issue or graded benefit final expense products are typically the only remaining options.

Kidney Transplant History — A successful kidney transplant with stable function and good eGFR can actually result in more favorable underwriting than advanced untransplanted CKD. Post-transplant cases are evaluated on current function, time since transplant, and immunosuppressant regimen.

CKD Stage: General Underwriting Outlook

CKD Stage / eGFR	Typical Rating	Best Achievable	Notes
Stage 1–2 (eGFR 60+), minimal proteinuria	Standard to Table 2	Standard at most carriers	Often treated similarly to healthy applicants
Stage 3a (eGFR 45–59), stable	Table 2–6	Table 2 at competitive carriers	Stable function and low proteinuria improve outcome
Stage 3b (eGFR 30–44), stable	Table 6–10	Table 6 at select carriers	Limited options; specialty carriers may be needed
Stage 4 (eGFR 15–29)	Decline at most standard carriers	Simplified issue	Very limited fully underwritten options
Stage 5 / Dialysis (eGFR under 15)	Decline at all standard carriers	Guaranteed issue only	Guaranteed issue with graded benefit is typically the only path
Post-transplant, stable function, 2+ years out	Table 4–8	Table 4 at select carriers	Better than advanced untransplanted CKD in many cases

Guidelines current as of 2025–2026. Verify with us before applying.

Situations That Typically Result in Decline

Dialysis Dependency — Any current dialysis use results in decline at all fully underwritten carriers. Guaranteed issue products are the primary remaining option.

Rapidly Declining Function — Even at Stage 3, a rapid decline in eGFR over 12–24 months signals progression toward dialysis and results in decline or postponement at most carriers regardless of the current level.

CKD with Significant Co-Morbidities — CKD combined with diabetes and hypertension — the two most common underlying causes — compounds risk substantially. Each condition is evaluated independently, and the combined profile is more restrictive than any single component.

What You Can Do to Improve Your Outcome

Apply while function is still preserved. CKD is progressive in most cases. Applying at Stage 2–3a rather than waiting until Stage 3b or 4 can mean the difference between standard rates and decline. Do not delay if your function is currently in a favorable range.

Control the underlying cause. Managing diabetes and hypertension optimally slows CKD progression. Improved control before applying — demonstrated by stable or improving eGFR over 6–12 months — can meaningfully improve your underwriting outcome.

Work with a specialist broker for CKD cases. The difference between carriers on CKD is significant — particularly for Stage 3. Applying to the wrong carrier first creates a decline on your MIB record that complicates future applications.

Have Kidney Disease? Let’s Review Your Options.

CKD underwriting is directly tied to your current kidney function numbers. We evaluate your specific eGFR and profile against current carrier guidelines before any application is submitted.

Call 1-888-972-0024

Browse All High-Risk Conditions

Understanding Your Rating: Life Insurance Risk Classifications | Table Ratings Explained (B–J) | Flat Extra Ratings

Authoritative Resources: Life insurance underwriting practices are regulated by the NAIC. Insurers may check your health history through the MIB Group — you can request your free annual MIB report at mib.com.

Frequently Asked Questions

Can I get life insurance with chronic kidney disease (CKD)?

Yes. CKD Stage 1 to 2 with preserved kidney function (eGFR above 60) often qualifies at standard or near-standard rates. Stage 3a (eGFR 45 to 59) typically results in table ratings. Stage 3b (eGFR 30 to 44) has more limited options. CKD Stage 4 to 5 or dialysis dependency typically results in decline at standard fully underwritten carriers, with guaranteed issue products remaining available.

What eGFR level do I need to get life insurance?

There is no absolute cutoff, but eGFR above 60 is the most favorable range and is generally insurable at standard rates at most carriers. eGFR between 45 and 59 (Stage 3a) results in table-rated offers at many carriers. eGFR between 30 and 44 (Stage 3b) has very limited options at select carriers. Below 30 typically results in decline at fully underwritten carriers.

Does dialysis prevent me from getting life insurance?

Traditional fully underwritten life insurance is not available for applicants currently on dialysis. Guaranteed issue whole life insurance, which requires no medical questions and no health examination, remains accessible and can provide meaningful coverage regardless of dialysis status. Coverage limits are typically capped at five thousand to twenty-five thousand dollars.

How does a kidney transplant affect life insurance underwriting?

A successful kidney transplant can actually improve your underwriting outlook compared to advanced untransplanted CKD. Most carriers evaluate post-transplant applicants on current kidney function (eGFR and creatinine), time since transplant, absence of rejection episodes, and immunosuppressant regimen. Many post-transplant applicants qualify for table-rated coverage two to five years after a successful transplant with stable function.

What is the most important thing I can do to improve my CKD life insurance outcome?

Apply while your kidney function is still in a favorable range. CKD is progressive in most cases, and applying at Stage 2 to 3a rather than waiting until Stage 3b or 4 can mean the difference between table-rated coverage and decline. Additionally, controlling the underlying cause — particularly diabetes and hypertension — and demonstrating stable or improving eGFR over 6 to 12 months significantly improves your underwriting profile.